Imbria Pharmaceuticals is Biotechnology in United States that focus on cellular metabolism business. Founded in 2018. They cover business area such as developer, biotechnology medicine, cellular metabolism, innovative medicine, patient, limited or inadequate treatment option, new treatment, energy, healthcare provider, transformative medicine.
2018
( 6 years old in 2024 )
Cellular Metabolism
-
265 Franklin Street
Suite 1702
Boston, MA 02110
United States
Private
developerbiotechnology medicinecellular metabolisminnovative medicinepatientlimited or inadequate treatment optionnew treatmentenergyhealthcare providertransformative medicine
* We use standard office opening hours in near Imbria Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Imbria Pharmaceuticals is Biotechnology business from United States that founded in 2018 (6 years old in 2024), Imbria Pharmaceuticals business is focusing on Cellular Metabolism.
Imbria Pharmaceuticals headquarter office and corporate office address is located in 265 Franklin Street Suite 1702 Boston, MA 02110 United States.
Imbria Pharmaceuticals was founded in United States.
In 2024, Imbria Pharmaceuticals is currently focus on cellular metabolism sector.
Above is snippet of Google Trends for "cellular metabolism" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Imbria Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
